Markus Lusser, President of Abcam (PRNewsfoto/Abcam)
CAMBRIDGE, England, March 18, 2024 /PRNewswire/ — Abcam announced the appointment of Markus Lusser as President.
Markus joined Abcam at a pivotal moment as the company transitions into the Danaher Life Sciences portfolio. With extensive experience in the life sciences and medical device industries, Markus aims to enhance Abcam’s innovative solutions for customers.
He previously served in leadership roles at Danaher and Siemens Healthineers, driving growth and innovation. Markus emphasizes building customer-centric cultures and fostering cross-functional teamwork.
His mission as Abcam’s President is to prioritize customer needs, collaboration, and innovation. Markus replaces Alan Hirzel as CEO. Abcam, headquartered in Cambridge, UK, operates globally and serves researchers worldwide with its biological reagents and solutions.
The opening ceremony witnessed the presence of senior representatives from diplomatic missions, government agencies, trade…
Malaysian businesses prepare for US-Iran tensions by strengthening risk strategies to ensure stability amid potential…
The US will impose 10% to 12.5% tariffs on 60 trading partners over forced labor…
KIPREIT posts record FY26, strong outlook with Setapak Central acquisition, AEIs, and rental reversions supporting…
Analysts expect cautious trading in KLCI today due to Wall Street declines, new tariffs, and…
Rystad warns oil prices hinge on resilience of flows, with escalation risks tightening markets and…
This website uses cookies.
